ATE182592T1 - Terazosinmonohydrochlorid und verfahren und zwischenprodukte für seine herstellung - Google Patents

Terazosinmonohydrochlorid und verfahren und zwischenprodukte für seine herstellung

Info

Publication number
ATE182592T1
ATE182592T1 AT95103186T AT95103186T ATE182592T1 AT E182592 T1 ATE182592 T1 AT E182592T1 AT 95103186 T AT95103186 T AT 95103186T AT 95103186 T AT95103186 T AT 95103186T AT E182592 T1 ATE182592 T1 AT E182592T1
Authority
AT
Austria
Prior art keywords
monohydrochloride
production
methods
terazosine
intermediate products
Prior art date
Application number
AT95103186T
Other languages
English (en)
Inventor
James A Morley
John F Bauer
Ramesh R Patel
Stephen G Spanton
Rodger F Henry
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22931058&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE182592(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE182592T1 publication Critical patent/ATE182592T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT95103186T 1994-05-20 1995-03-06 Terazosinmonohydrochlorid und verfahren und zwischenprodukte für seine herstellung ATE182592T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/246,526 US5412095A (en) 1993-04-29 1994-05-20 Terazosin monohydrochloride and processes and intermediate for its production

Publications (1)

Publication Number Publication Date
ATE182592T1 true ATE182592T1 (de) 1999-08-15

Family

ID=22931058

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95103186T ATE182592T1 (de) 1994-05-20 1995-03-06 Terazosinmonohydrochlorid und verfahren und zwischenprodukte für seine herstellung

Country Status (10)

Country Link
US (1) US5412095A (de)
EP (1) EP0683167B1 (de)
JP (1) JP2755918B2 (de)
AT (1) ATE182592T1 (de)
CA (1) CA2143974C (de)
DE (2) DE683167T1 (de)
DK (1) DK0683167T3 (de)
ES (1) ES2093579T3 (de)
GR (2) GR960300046T1 (de)
HK (1) HK1012629A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587377A (en) * 1995-10-24 1996-12-24 Invamed, Inc. Terazosin crystalline polymorph and pharmaceutical compositions thereof
DE19546573A1 (de) * 1995-12-13 1997-06-19 Uetikon Chemie Gmbh Kristallines Polymorph von Terazosin-Hydrochlorid, sowie Verfahren zu seiner Herstellung
US5952003A (en) * 1996-08-01 1999-09-14 Novartis Corporation Terazosin capsules
IT1286790B1 (it) * 1996-11-29 1998-07-17 Alfa Chem Ital Processo per la produzione della forma i del terazosin monocloridrato anidro
IT1286789B1 (it) * 1996-11-29 1998-07-17 Alfa Chem Ital Processo per la produzione della forma i del terazosin monocloridato anidro
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
EP0849264A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von doxazosinmesylat (Form I)
PT849266E (pt) * 1996-12-20 2007-03-30 Heumann Pcs Gmbh Nova forma polimorfa de mesilato de doxazosina (forma iii)
US6248888B1 (en) 1997-11-14 2001-06-19 Teva Pharmaceutical Industries Ltd. Process for the preparation of terazosin hydrochloride dihydrate
US6200573B1 (en) 1999-12-03 2001-03-13 Starcor Pharmaceuticals, Inc. Method of medical management for lower urinary tract symptoms and benign prostatic hyperplasia
US20030068829A1 (en) * 2001-06-25 2003-04-10 Symyx Technologies, Inc. High throughput crystallographic screening of materials
TWI353979B (en) * 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
WO2008021891A2 (en) * 2006-08-08 2008-02-21 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
GB1591490A (en) * 1977-08-04 1981-06-24 Abbott Lab 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
ATE72244T1 (de) * 1986-03-21 1992-02-15 Heumann Pharma Gmbh & Co Kristalline, wasserfreie sigma -form von 2-(4-(2furoyl-(2-piperazin)-1-yl>-4-amino-6,7- dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung.
US5212176A (en) * 1990-06-29 1993-05-18 Abbott Laboratories R(+)-terazosin
JP2652272B2 (ja) * 1990-12-31 1997-09-10 住化ファインケム株式会社 １−（４−アミノ−６，７−ジメトキシ−２−キナゾリニル）−４−（２−テトラヒドロフロイル）ピペラジン塩酸塩の新規な結晶体および該結晶体の製造方法
US5294615A (en) * 1993-04-29 1994-03-15 Abbott Laboratories Terazosin polymorph and pharmaceutical composition

Also Published As

Publication number Publication date
CA2143974C (en) 1997-06-03
JP2755918B2 (ja) 1998-05-25
EP0683167A1 (de) 1995-11-22
DE69510999D1 (de) 1999-09-02
EP0683167B1 (de) 1999-07-28
US5412095A (en) 1995-05-02
ES2093579T1 (es) 1997-01-01
DK0683167T3 (da) 2000-02-07
CA2143974A1 (en) 1995-11-21
ES2093579T3 (es) 1999-11-01
DE69510999T2 (de) 2000-02-17
JPH0848685A (ja) 1996-02-20
GR3031248T3 (en) 1999-12-31
GR960300046T1 (en) 1996-08-31
HK1012629A1 (en) 1999-08-06
DE683167T1 (de) 1996-11-07

Similar Documents

Publication Publication Date Title
ATE182592T1 (de) Terazosinmonohydrochlorid und verfahren und zwischenprodukte für seine herstellung
NO303574B1 (no) Ny fremgangsmÕte for fremstilling av 9-amino-6-demetyl-6-deoksytetracykliner
ATE260919T1 (de) Zwischenprodukte für die herstellung von pharmazeutischem camptothecin
DE69513884D1 (de) Katalysator für die Herstellung der Akrylsäure und Verfahren zur Herstellung der Akrylsäure unter Verwendung des Katalysators
DK0535928T3 (da) Fremgangsmåde til fremstilling af mellemprodukter til anvendelse i fremstilling af alkoxyiminoacetamider
ATE239008T1 (de) Verfahren zur herstellung von (+/-) calanolide a und zwischenprodukte dafür
DE69132276D1 (de) Verfahren zur herstellung von nukleotiden
ATE207884T1 (de) Verfahren zur herstellung von aminobenzol- derivaten
DE69929079D1 (de) Zwischenstufe für die synthese von amlodipin, herstellungsverfahren und entsprechende anwendung
DE69312913D1 (de) Verfahren zur herstellung von zwischenprodukten für die synthese von chinolin-antibiotika
DE3767993D1 (de) Verfahren zur herstellung von thienylaethylaminen, und mittels des verfahrens hergestellte dithienylaethylamine.
ATE457972T1 (de) Verfahren zur herstellung von 7-amino-syn-3,5- dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
DE69907656D1 (de) Polyethoxylierte retinamid-derivate und verfahren zu ihrer herstellung
DE69228226D1 (de) Verfahren zur Herstellung von 2-Amino-6-Halogenopurin und Synthese einer Zwischenverbindung
DE69404409D1 (de) Verfahren zur Herstellung von Ceramiden
ATE171942T1 (de) 1-piperazinyl-2-butene und 2-butyne, zwischenverbindungen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
YU46961B (sh) Postupak za konverziju polimorfnog kristalnog oblika buspiron hlorhidrata
ATE5077T1 (de) 22-arylsulfonyl-24,25-dihydroxy-cholestane und verfahren zu ihrer herstellung.
ATE234288T1 (de) Verfahren zur herstellung eines buthylthuio- isochinolinderivates und zwischenprodukte dafür
ATE131155T1 (de) Verfahren zur herstellung von zwischenprodukten und zur synthese von n-(2-hydroxyethyl)-2- hydroxymethyl-3,4,5-trihydroxypiperidine.
SE9300455D0 (sv) Mellanprodukt vid framstaellning av histamin h2-antagonister
ATE130840T1 (de) Verfahren zur herstellung von optisch-aktivem zyklobutanon, ein zwischenprodukt in der synthese von optisch-aktiven zyklobutanonnukleosiden.
ATE226570T1 (de) Verfahren zur herstellung von halogenacetamidderivaten
DE69229017D1 (de) Glyceraldehyd-3-pentanid und Verfahren zu ihrer Herstellung
DK0492350T3 (da) Fremgangsmåde til fremstilling af (S)-vinyl- og (S)-allenyl-GABA

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee